Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 1
1971 3
1972 1
1973 3
1974 3
1976 1
1981 2
1983 1
1985 3
1986 2
1987 3
1988 4
1989 4
1990 2
1991 3
1992 6
1993 1
1994 5
1995 13
1996 15
1997 29
1998 25
1999 31
2000 35
2001 42
2002 69
2003 70
2004 66
2005 83
2006 100
2007 132
2008 135
2009 168
2010 166
2011 192
2012 219
2013 229
2014 207
2015 238
2016 242
2017 258
2018 260
2019 250
2020 271
2021 307
2022 265
2023 251
2024 172
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

4,057 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. Among authors: kim ym. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Clinical Trial.
Survival with Cemiplimab in Recurrent Cervical Cancer.
Tewari KS, Monk BJ, Vergote I, Miller A, de Melo AC, Kim HS, Kim YM, Lisyanskaya A, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin EA, Takahashi S, Ramone D, Pikiel J, Maćkowiak-Matejczyk B, Guerra Alía EM, Colombo N, Makarova Y, Rischin D, Lheureux S, Hasegawa K, Fujiwara K, Li J, Jamil S, Jankovic V, Chen CI, Seebach F, Weinreich DM, Yancopoulos GD, Lowy I, Mathias M, Fury MG, Oaknin A; Investigators for GOG Protocol 3016 and ENGOT Protocol En-Cx9. Tewari KS, et al. Among authors: kim ym. N Engl J Med. 2022 Feb 10;386(6):544-555. doi: 10.1056/NEJMoa2112187. N Engl J Med. 2022. PMID: 35139273 Clinical Trial.
Nitric oxide and intracellular heme.
Kim YM, Bergonia HA, Müller C, Pitt BR, Watkins WD, Lancaster JR Jr. Kim YM, et al. Adv Pharmacol. 1995;34:277-91. doi: 10.1016/s1054-3589(08)61092-3. Adv Pharmacol. 1995. PMID: 8562440 Review.
Regulation of caspases by nitric oxide.
Kim PK, Kwon YG, Chung HT, Kim YM. Kim PK, et al. Among authors: kim ym. Ann N Y Acad Sci. 2002 May;962:42-52. doi: 10.1111/j.1749-6632.2002.tb04054.x. Ann N Y Acad Sci. 2002. PMID: 12076961 Review.
The ins and outs of G protein-coupled receptor trafficking.
Marchese A, Chen C, Kim YM, Benovic JL. Marchese A, et al. Among authors: kim ym. Trends Biochem Sci. 2003 Jul;28(7):369-76. doi: 10.1016/S0968-0004(03)00134-8. Trends Biochem Sci. 2003. PMID: 12878004 Review. No abstract available.
TLRs bent into shape.
Kim YM, Brinkmann MM, Ploegh HL. Kim YM, et al. Nat Immunol. 2007 Jul;8(7):675-7. doi: 10.1038/ni0707-675. Nat Immunol. 2007. PMID: 17579642 No abstract available.
Anti-inflammatory activity of Taraxacum officinale.
Jeon HJ, Kang HJ, Jung HJ, Kang YS, Lim CJ, Kim YM, Park EH. Jeon HJ, et al. Among authors: kim ym. J Ethnopharmacol. 2008 Jan 4;115(1):82-8. doi: 10.1016/j.jep.2007.09.006. Epub 2007 Sep 15. J Ethnopharmacol. 2008. PMID: 17949929
4,057 results